Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (511-520 of 633) with videos related to

Pageof 64
Sort By:
Annals of the Rheumatic Diseases|December 2, 2021
Digoxin targets low density lipoprotein receptor-related protein 4 and protects against osteoarthritisKai-di Wang, Xiang Ding, Nan Jiang, et al.
International Journal of Oncology|May 24, 2017
Uncaria alkaloids reverse ABCB1-mediated cancer multidrug resistanceBao-Yuan Huang, Yu Zeng, Ying-Jie Li, et al.
British Journal of Pharmacology|August 29, 2014
In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1Hui Zhang, Atish Patel, Shao-Lin Ma, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 26, 2021
Podophyllum hexandrum and its active constituents: Novel radioprotectantsUttpal Anand, Protha Biswas, Vinay Kumar, et al.
Molecular Therapy Oncolytics|July 17, 2020
A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT PathwayLiuya Wei, Yang Yang, Pranav Gupta, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 10, 2024
Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitorQiu-Xu Teng, Zi-Ning Lei, Jing-Quan Wang, et al.
Translational Lung Cancer Research|January 13, 2023
DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort studyZhiwei Xiao, Lingling Sun, Yating Zheng, et al.
European Journal of Pharmacology|September 3, 2019
Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistanceJing-Quan Wang, Bo Wang, Zi-Ning Lei, et al.
Oncotarget|October 31, 2015
A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivoNagaraju Anreddy, Atish Patel, Yun-Kai Zhang, et al.
Journal of Medicinal Chemistry|February 7, 2017
A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial PathwayShengtao Xu, Hong Yao, Shanshan Luo, et al.
Pageof 64

Showing results (511-520 of 633) with videos related to

Sort By:
Pageof 64
Annals of the Rheumatic Diseases|December 2, 2021
Digoxin targets low density lipoprotein receptor-related protein 4 and protects against osteoarthritisKai-di Wang, Xiang Ding, Nan Jiang, et al.
International Journal of Oncology|May 24, 2017
Uncaria alkaloids reverse ABCB1-mediated cancer multidrug resistanceBao-Yuan Huang, Yu Zeng, Ying-Jie Li, et al.
British Journal of Pharmacology|August 29, 2014
In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1Hui Zhang, Atish Patel, Shao-Lin Ma, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 26, 2021
Podophyllum hexandrum and its active constituents: Novel radioprotectantsUttpal Anand, Protha Biswas, Vinay Kumar, et al.
Molecular Therapy Oncolytics|July 17, 2020
A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT PathwayLiuya Wei, Yang Yang, Pranav Gupta, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 10, 2024
Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitorQiu-Xu Teng, Zi-Ning Lei, Jing-Quan Wang, et al.
Translational Lung Cancer Research|January 13, 2023
DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort studyZhiwei Xiao, Lingling Sun, Yating Zheng, et al.
European Journal of Pharmacology|September 3, 2019
Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistanceJing-Quan Wang, Bo Wang, Zi-Ning Lei, et al.
Oncotarget|October 31, 2015
A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivoNagaraju Anreddy, Atish Patel, Yun-Kai Zhang, et al.
Journal of Medicinal Chemistry|February 7, 2017
A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial PathwayShengtao Xu, Hong Yao, Shanshan Luo, et al.
Pageof 64